Rickman, David S; Beltran, Himisha; Demichelis, Francesca; Rubin, Mark Andrew (2017). Biology and evolution of poorly differentiated neuroendocrine tumors. Nature medicine, 23(6), pp. 664-673. Nature Publishing Group 10.1038/nm.4341
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
nm.4341.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (5MB) |
Neuroendocrine (NE) cancers are a diverse group of neoplasms typically diagnosed and treated on the basis of their site of origin. This Perspective focuses on advances in our understanding of the tumorigenesis and treatment of poorly differentiated neuroendocrine tumors. Recent evidence from sequencing indicates that, although neuroendocrine tumors can arise de novo, they can also develop as a result of lineage plasticity in response to pressure from targeted therapies. We discuss the shared genomic alterations of these tumors independently of their site of origin, and we explore potential therapeutic strategies on the basis of recent biological findings.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
UniBE Contributor: |
Rubin, Mark Andrew |
Subjects: |
500 Science 500 Science > 570 Life sciences; biology |
ISSN: |
1078-8956 |
Publisher: |
Nature Publishing Group |
Language: |
English |
Submitter: |
Marla Rittiner |
Date Deposited: |
02 Feb 2018 12:15 |
Last Modified: |
05 Dec 2022 15:10 |
Publisher DOI: |
10.1038/nm.4341 |
PubMed ID: |
28586335 |
BORIS DOI: |
10.7892/boris.110781 |
URI: |
https://boris.unibe.ch/id/eprint/110781 |
Actions (login required)
 |
Edit item |